Nov. 4, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on treating calcified arterial disease, presented the results of the first 95 patients treated in the POWER PAD II U.S. pivotal study for Pulsatile Intravascular Lithotripsy (PIVL) therapy as a Late Breaking Clinical Trial (LBCT) at the Vascular InterVentional Advances (VIVA) meeting in Las Vegas.

Nov. 3, 2025 — Penumbra, Inc. has announced additional results of the STORM-PE randomized controlled trial (RCT), which found that the use of computer assisted vacuum thrombectomy (CAVT) with anticoagulation achieved significantly greater improvements in thrombus burden reduction, heart rate, oxygen requirement and functional outcomes compared to anticoagulation alone in patients with acute intermediate-high risk pulmonary embolism (PE).

Nov. 4, 2025 – Johnson & Johnson MedTech has announced the one-year results in patients treated with its Shockwave Javelin Peripheral IVL Catheter, a novel Forward IVL platform designed to modify calcified occlusive or extremely narrowed lesions in patients with peripheral artery disease (PAD). The results, presented as a late-breaking clinical trial at the annual Vascular InterVentional Advances (VIVA) meeting, demonstrate low rates of major amputation and cardiovascular death in a high-risk, complex patient population. 

Nov. 3, 2025 — GE HealthCare and AliveCor recently announced the world’s first clinical go-live of the integration between GE HealthCare’s  MUSE Cardiology Information System and AliveCor’s KardiaMobile 6L electrocardiogram (ECG) device at Hannover Medical School (MHH), Germany. The collaboration aims to optimize patient care and reduce hospitalizations linked to cardiac events by expanding care outside the hospital with remote patient monitoring*.

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein graft (SVG) percutaneous coronary intervention (PCI) had better one-year clinical outcomes compared to native vessel PCI in patients who have previously undergone coronary artery bypass grafting (CABG).   

Findings were reported at TCT 2025 in San Francisco, the annual scientific symposium of the Cardiovascular Research Foundation (CRF) and also published simultaneously in the Journal of the American College of Cardiology. 

Oct. 30, 2025 — Recor Medical and its parent company, Otsuka Medical Devices presented the results from two clinical studies presented at the recent 2025 Transcatheter Cardiovascular Therapeutics (TCT) conference.

Oct. 29, 2025 — Circle Cardiovascular Imaging Inc., a provider of cardiovascular imaging solutions, recently announced that its cvi42 | Plaque solution has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available for clinical use in the United States. This  AI-enabled solution allows clinicians to perform comprehensive coronary plaque analysis directly on-premise, enhancing diagnostic workflows and patient care.

Oct. 22, 2025 -- Medical robotics innovator Noah Medical presented two new data sets highlighting the clinical and economic performance of the company’s Galaxy System, a next-generation Robotic-Assisted Bronchoscopy platform.

Oct. 23, 2025 — At TCT 2025, the Cardiovascular Research Foundation (CRF) announced the 2025 SET-10 (Scientific Excellence Top 10), recognizing the academic and medical institutions driving the most impactful interventional cardiovascular research.

Launched in 2023, the SET-10 honors institutions whose groundbreaking research is shaping the future of cardiovascular care and advancing the science that saves lives.

Oct. 28, 2025 — Bronchopulmonary dysplasia (BPD) is the most common — and most serious — complication of extreme prematurity. Yet clinicians still lack a reliable way to measure the severity of the disease or predict which infants will need long-term respiratory support.

Now, researchers at Children’s Hospital Los Angeles (CHLA) are investigating low-field MRI to safely capture both lung structure and function in these babies — offering a new window into how their fragile lungs develop.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now